Clinical Trials
7 trialsNCT07410494 2026-02-18
SELECT-CAR-NK
Essen Biotech
Phase 1/2 Recruiting
NCT04094610 2025-11-19
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Turning Point Therapeutics, Inc.
Phase 1/2 Recruiting
NCT06506643 2024-10-01
Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms
Vector Vitale LLC
Phase 1/2 Recruiting
NCT05842785 2024-07-29
TSN222 in Subjects With Advanced Solid Tumors or Lymphomas
Tyligand Bioscience (Shanghai) Limited
Phase 1/2 Recruiting
NCT05390528 2023-08-08
HLX301
Shanghai Henlius Biotech
Phase 1/2 Unknown
NCT04873440 2021-05-05
An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT02722551 2018-01-09
RELIEF
Edwards Lifesciences
Phase 1/2 Withdrawn